Загрузка...
Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation
Advanced human thyroid cancers, particularly those that are refractory to treatment with radioiodine (RAI), have a high prevalence of BRAF (v-raf murine sarcoma viral oncogene homolog B1) mutations. However, the degree to which these cancers are dependent on BRAF expression is still unclear. To addr...
Сохранить в:
| Главные авторы: | , , , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society for Clinical Investigation
2011
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3225989/ https://ncbi.nlm.nih.gov/pubmed/22105174 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI46382 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|